Richard Haass, former President of the Council on Foreign Relations, explains how the geopolitical landscape is shifting and what it means for markets and global stability. Max Kettner, Chief Multi-Asset Strategist at HSBC, breaks down the market impact and how investors should be positioned amid volatility. Paul Sankey of Sankey Research dives into the oil market gyrations. Former CEA member Jared Bernstein discusses where the economy stands and what comes next for growth, policy and the labor market. Richard Bernstein of Janus Henderson outlines what could drive markets in the week ahead as investors prepare for key jobs data.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

From the open to the close, “Closing Bell” and “Closing Bell: Overtime” have you covered. From what’s driving market moves to how investors are reacting, Scott Wapner, Melissa Lee and Michael Santoli guide listeners through each trading session and bring to you some of the biggest names in business. 

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Bob Diamond, CEO of Atlas Merchant Capital and former Barclays CEO, joins to assess market conditions, policy risk and where investors should be focusing now. The show also explores growing buzz around a potential SpaceX IPO and what a deal of that size could mean for markets and investor demand. Nike remains under pressure. Williams Trading analyst Sam Poser explains why he is sticking with a Buy rating even after lowering his price target and why the turnaround may take longer than expected. On the 50th anniversary of Apple’s founding, we look at the next stage of the company’s evolution. Sebastien Page, CIO of T. Rowe Price, outlines the broader investment landscape and how portfolios should be positioned. Christopher Verrone of Strategas walks through the technical setup and key levels investors should watch.
Our Angelica Peebles reports on the FDA approval of Eli Lilly’s daily GLP-1 pill and what it could mean for the weight loss drug market and healthcare stocks. The episode closes with a look ahead at the next catalysts for markets.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.